Taiko Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	5,942	6,292	6,120	5,040	11,299	22,456
Revenue Growth (YoY)	-5.41%	2.81%	21.43%	-55.39%	-49.68%	50.05%
Cost of Revenue	2,630	2,626	3,543	3,961	8,552	6,917
Gross Profit	3,312	3,666	2,577	1,079	2,747	15,539
Selling, General & Admin	3,084	3,036	3,583	4,157	7,694	9,294
Operating Expenses	3,084	3,036	3,583	4,157	7,694	9,267
Operating Income	228	630	-1,006	-3,078	-4,947	6,272
Interest Expense	-6	-8	-8	-10	-6	-
Interest & Investment Income	21	30	25	5	3	8
Currency Exchange Gain (Loss)	193	39	31	59	50	-35
Other Non Operating Income (Expenses)	1	-2	-291	-330	-1,231	-226
EBT Excluding Unusual Items	437	689	-1,249	-3,354	-6,131	6,019
Gain (Loss) on Sale of Investments	357	6	193	-82	60	-
Gain (Loss) on Sale of Assets	-	-	76	-	-	-
Asset Writedown	-18	-240	-2,506	-98	-2,456	-106
Legal Settlements	-	-	-	-499	-359	-62
Other Unusual Items	-74	111	-78	-837	-2	-41
Pretax Income	713	566	-3,564	-4,870	-8,888	5,810
Income Tax Expense	-140	-332	47	25	706	1,632
Net Income	853	898	-3,611	-4,895	-9,594	4,178
Net Income to Common	853	898	-3,611	-4,895	-9,594	4,178
Net Income Growth	-	-	-	-	-	70.32%
Shares Outstanding (Basic)	50	50	47	44	44	43
Shares Outstanding (Diluted)	50	50	47	44	44	43
Shares Change (YoY)	0.25%	5.96%	8.62%	0.21%	0.35%	1.32%
EPS (Basic)	16.98	17.89	-76.25	-112.27	-220.51	96.96
EPS (Diluted)	16.98	17.89	-76.25	-112.27	-220.51	96.37
EPS Growth	-	-	-	-	-	68.07%
Free Cash Flow	-	205	-404	-2,058	-3,071	-4,881
Free Cash Flow Per Share	-	4.08	-8.53	-47.20	-70.58	-112.59
Dividend Per Share	-	-	-	-	-	23.667
Dividend Growth	-	-	-	-	-	136.67%
Gross Margin	55.74%	58.26%	42.11%	21.41%	24.31%	69.20%
Operating Margin	3.84%	10.01%	-16.44%	-61.07%	-43.78%	27.93%
Profit Margin	14.36%	14.27%	-59.00%	-97.12%	-84.91%	18.61%
Free Cash Flow Margin	-	3.26%	-6.60%	-40.83%	-27.18%	-21.74%
EBITDA	486	886	-302	-2,341	-4,006	6,901
EBITDA Margin	8.18%	14.08%	-4.93%	-46.45%	-35.45%	30.73%
D&A For EBITDA	258	256	704	737	941	629.33
EBIT	228	630	-1,006	-3,078	-4,947	6,272
EBIT Margin	3.84%	10.01%	-16.44%	-61.07%	-43.78%	27.93%
Effective Tax Rate	-	-	-	-	-	28.09%
Advertising Expenses	-	767	979	806	3,005	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.